- cafead May 16, 2024 at 12:02: PM
via Vanda Pharmaceuticals has reported positive outcomes from its second Phase III clinical trial of tradipitant, aimed at treating motion sickness.
Dubbed Motion Serifos, the double-blind, randomised, multicentre, placebo-controlled trial involved 316 participants with a history of motion sickness.
article source
Dubbed Motion Serifos, the double-blind, randomised, multicentre, placebo-controlled trial involved 316 participants with a history of motion sickness.
article source